Authors : Darshitaa Manjunatha Nanjundappa; Sara Mohamed Rafeeq; Ponnuri Shanmukha Sai Abhishek; Divina Mariya Puthooran; Nakul P Jinde

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/jdkbbedb

Scribd : https://tinyurl.com/ykf3zj4p

DOI : https://doi.org/10.38124/ijisrt/25aug003

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Adult Congenital Heart Disease (ACHD) is an anatomical anomaly of the heart or the great vessels. Today, ACHD, according to the 2018 AHA guidelines and 2020 ESC guidelines, corresponds to its anatomical and physiological flaws. Along with these congenital lesions, ACHD can further be combined with Eisenmenger syndrome, backed up by Pulmonary Hypertension. Apart from these, existing comorbidities like Heart Failure or structural valvular issues in ACHD patients add to the numerous challenges faced to survive into adulthood. Aiding clinicians in diagnosing ACHD is Echocardiography, Heart CT angiography and Heart MRI. Usually, other differential diagnoses must be eliminated to establish a confirmed diagnosis of ACHD, following a detailed patient and family history, backed up by genetic testing. Based on each patient's unique anatomy, clinical condition, and long-term health objectives, the care of ACHD is a multifaceted and protracted procedure that includes preventive, surgical and interventional techniques, rhythm management, and psychosocial support. Gradually changing its emphasis from primary surgery to the careful management of acquired comorbidities, late complications, and residual abnormalities. Limited anatomical defect care is giving way to an era of advancements marked by proactive and individualised strategies. Ongoing research is enabling innovations that integrate regenerative medicine, artificial intelligence, imaging, and new and improved devices. This paper reviews the essential details of ACHD and stresses the importance of advanced diagnostic modalities and associated therapy for better care and survival of patients with ACHD.

Keywords : Adult Congenital Heart Disease, Congenital Heart Disease, Cyanotic Heart Lesions, Acyanotic Heart Lesions, Eisenmenger Syndrome.

References :

1. A. M. E. A. A. Mahmod and S. H. M. Koko, "Adult congenital heart diseases: systematic review/meta-analysis," Annals of Medicine and Surgery (2012), vol. 86, no. 3, pp. 1606–1612, 2024, doi: 10.1097/MS9.0000000000001704.
2. M. Fabbri and A. Sahu, "Challenges and opportunities in patients with adult congenital heart disease, a narrative review," Frontiers in Cardiovascular Medicine, vol. 11, p. 1366572, 2024, doi: 10.3389/fcvm.2024.1366572.
3. F. Bajwa, S. M. Jafri, and K. Ananthasubramaniam, "A Review of Selected Adult Congenital Heart Diseases Encountered in Daily Practice," Current Cardiology Reviews, vol. 17, no. 3, pp. 260–278, 2021, doi: 10.2174/1573403X16666200810104615
4. R. A. Lindor et al., "Adult Congenital Heart Disease in the Emergency Department," Journal of Personalized Medicine, vol. 14, no. 1, p. 66, 2024, doi: 10.3390/jpm14010066.  
5. A. J. Small, M. Dai, D. G. Halpern, and R. B. Tan, "Updates in Arrhythmia Management in Adult Congenital Heart Disease," Journal of Clinical Medicine, vol. 13, no. 15, p. 4314, 2024, doi: 10.3390/jcm13154314.
6. V. Carvajal et al., "Endocarditis in Adult Congenital Heart Disease Patients: Prevention, Recognition, and Management," Current Cardiology Reports, vol. 26, no. 9, pp. 1031–1045, 2024, doi: 10.1007/s11886-024-02103-9.
7. G. Hickey et al., "Long-Term outcomes in adult patients with congenital heart disease considered for transplantation: A single-centre study," Clinical Transplantation, vol. 37, no. 11, e15101, 2023, doi: 10.1111/ctr.15101.
8. K. K. Stout et al., “2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease: Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,” Circulation, vol. 139, no. 14, Oct. 2018, doi: 10.1161/cir.0000000000000602.
9. F. Ombelet, E. Goossens, A. Van De Bruaene, W. Budts, and P. Moons, "Newly developed adult congenital heart Disease Anatomic and Physiological Classification: First predictive validity evaluation," Journal of the American Heart Association, vol. 9, no. 5, 2020, doi: 10.1161/jaha.119.014988.
10. H. Baumgartner et al., “2020 ESC Guidelines for the management of adult congenital heart disease,” European Heart Journal, vol. 42, no. 6, pp. 563–645, Aug. 2020, doi: 10.1093/eurheartj/ehaa554.
11. K. K. Stout et al., “2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,” Circulation, vol. 139, no. 14, Oct. 2018, doi: 10.1161/cir.0000000000000603.
12. J. Singh and A. Wanjari, “Cardiac complications in Marfan Syndrome: a review,” Cureus, Sep. 2022, doi: 10.7759/cureus.29800.
13. M. Silberbach et al., “Cardiovascular health in Turner Syndrome: A scientific statement from the American Heart Association,” Circulation Genomic and Precision Medicine, vol. 11, no. 10, Oct. 2018, doi: 10.1161/hcg.0000000000000048.
14. W. Vongpatanasin, “The Eisenmenger syndrome in adults,” Annals of Internal Medicine, vol. 128, no. 9, p. 745, May 1998, doi: 10.7326/0003-4819-128-9-199805010-00008.
15. “Classes and stages of heart failure,” American Heart Association, May 21, 2025. https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure.
16. L. A. Goeddel, Y. H. Jung, P. Patel, P. Upchurch, R. J. Fernando, and H. Ramakrishna, “Analysis of the 2018 American Heart Association/American College of Cardiology Guidelines for the Management of Adults with Congenital Heart Disease: Implications for the Cardiovascular Anesthesiologist,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 34, no. 5, pp. 1348–1365, Aug. 2019, doi: 10.1053/j.jvca.2019.08.004.
17. Q. Fan, Y. Wang, Q. An, and Y. Ling, "Right ventricular dysfunction following tetralogy of Fallot correction: Anatomical determinants and therapeutic strategies," International Journal of Surgery, vol. 111, no. 6, pp. 3979–3988, 2025, doi: 10.1097/JS9.0000000000002367.
18. T. Geva et al., "Long-term management of right ventricular outflow tract dysfunction in repaired Tetralogy of Fallot: A scientific statement from the American Heart Association," Circulation, vol. 150, no. 25, pp. e689–e707, 2024, doi: 10.1161/CIR.0000000000001291.
19. F. Bessière et al., "Ventricular arrhythmias in adults with congenital heart disease, part II: JACC state-of-the-art review," Journal of the American College of Cardiology, vol. 82, no. 11, pp. 1121–1130, 2023, doi: 10.1016/j.jacc.2023.06.036.
20. N. Schamroth Pravda et al., "Arrhythmia burden among adult patients with congenital heart disease: A population-based study," Journal of the American Heart Association, vol. 13, no. 9, e031760, 2024, doi: 10.1161/JAHA.123.031760.
21. J. Francisco-Pascual, N. Mallofré Vila, A. Santos-Ortega, and N. Rivas-Gándara, "Tachyarrhythmias in congenital heart disease," Frontiers in Cardiovascular Medicine, vol. 11, p. 1395210, 2024, doi: 10.3389/fcvm.2024.1395210.
22. A. Hernández-Madrid et al., "Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), AEPC, and ESC Working Group on grown-up congenital heart disease," Europace, vol. 20, no. 11, pp. 1719–1753, 2018, doi: 10.1093/europace/eux380.
23. B. J. Bouma et al., "New developments in adult congenital heart disease," Netherlands Heart Journal, vol. 28, Suppl 1, pp. 44–49, 2020, doi: 10.1007/s12471-020-01455-5.
24. K. L. Losenno, R. L. Goodman, and M. W. Chu, "Bicuspid aortic valve disease and ascending aortic aneurysms: Gaps in knowledge," Cardiology Research and Practice, vol. 2012, Article ID 145202, 2012, doi: 10.1155/2012/145202.
25. J. P. van Melle et al., "Infective endocarditis in adult patients with congenital heart disease," International Journal of Cardiology, vol. 370, pp. 178–185, 2023, doi: 10.1016/j.ijcard.2022.10.136.
26. M. Fedchenko, K. W. Giang, U. Snygg-Martin, M. Dellborg, and Z. Mandalenakis, "Risk and predictors of first-time infective endocarditis in adult patients with congenital heart disease: A nationwide, register-based study," International Journal of Cardiology, vol. 426, p. 133081, 2025, doi: 10.1016/j.ijcard.2025.133081.
27. M. Malahfji and M. A. Chamsi-Pasha, "Advanced cardiac imaging for complex adult congenital heart diseases," Methodist DeBakey Cardiovascular Journal, vol. 15, no. 2, pp. 99–104, 2019, doi: 10.14797/mdcj-15-2-99.
28. K. Havasi, N. Ambrus, A. Kalapos, T. Forster, and A. Nemes, "The role of echocardiography in the management of adult patients with congenital heart disease following operative treatment," Cardiovascular Diagnosis and Therapy, vol. 8, no. 6, pp. 771–779, 2018, doi: 10.21037/cdt.2018.09.11.
29. J. Rizk, "4D flow MRI applications in congenital heart disease," European Radiology, vol. 31, no. 2, pp. 1160–1174, 2021, doi: 10.1007/s00330-020-07210-z.
30. J. Urmeneta Ulloa, A. Álvarez Vázquez, V. Martínez de Vega, and J. Á. Cabrera, "Evaluation of cardiac shunts with 4D flow cardiac magnetic resonance: Intra- and interobserver variability," Journal of Magnetic Resonance Imaging, vol. 52, no. 4, pp. 1055–1063, 2020, doi: 10.1002/jmri.27158.
31. S. Edpuganti, A. Shamim, V. H. Gangolli, R. a. D. K. N. W. Weerasekara, and A. Yellamilli, "Artificial intelligence in cardiovascular imaging: current landscape, clinical impact, and future directions," Discoveries, vol. 13, no. 2, e211, 2025, doi: 10.15190/d.2025.10.
32. J. R. Ghadri et al., "Congenital coronary anomalies detected by coronary computed tomography compared to invasive coronary angiography," BMC Cardiovascular Disorders, vol. 14, p. 81, 2014, doi: 10.1186/1471-2261-14-81.
33. N. Szugye, "Greater than the sum of its parts: Multimodality imaging in adults with congenital heart disease," Cardiovascular Diagnosis and Therapy, vol. 14, no. 6, pp. 1176–1185, 2024, doi: 10.21037/cdt-24-363.
34. W. R. Miranda, J. A. Aboulhosn, and D. J. Hagler, "Catheterization in adults with congenital heart disease: A primer for the noncongenital proceduralist," JACC: Cardiovascular Interventions, vol. 15, no. 9, pp. 907–921, 2022, doi: 10.1016/j.jcin.2021.12.020.
35. J. A. Groeneweg et al., "2023 European Society of Cardiology guidelines on the management of cardiomyopathies: Statement of endorsement by the NVVC," Netherlands Heart Journal, vol. 33, no. 5, pp. 148–156, 2025, doi: 10.1007/s12471-025-01955-2.
36. M. Brida et al., “Atrial septal defect in adulthood: a new paradigm for congenital heart disease,” European Heart Journal, vol. 43, no. 28, pp. 2660–2671, Sep. 2021, doi: 10.1093/eurheartj/ehab646.
37. E. A. Bradley et al., “‘Treat-to-close’: Non-repairable ASD-PAH in the adult,” International Journal of Cardiology, vol. 291, pp. 127–133, Apr. 2019, doi: 10.1016/j.ijcard.2019.03.056.
38. N. Skoro-Sajer et al., “Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension,” Heart, vol. 104, no. 14, pp. 1195–1199, Feb. 2018, doi: 10.1136/heartjnl-2017-312143.
39. V. Regitz-Zagrosek et al., “2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy,” European Heart Journal, vol. 39, no. 34, pp. 3165–3241, Aug. 2018, doi: 10.1093/eurheartj/ehy340.
40. G.-P. Diller, A. E. Lammers, and E. Oechslin, “Treatment of adults with Eisenmenger syndrome—state of the art in the 21st century: a short overview,” Cardiovascular Diagnosis and Therapy, vol. 11, no. 4, pp. 1190–1199, Jul. 2021, doi: 10.21037/cdt-21-135.
41. P. Evans, D. O’Reilly, J. N. Flyer, S. Mitra, and R. Soll, “Indomethacin for symptomatic patent ductus arteriosus in preterm infants,” Cochrane Library, Sep. 2018, doi: 10.1002/14651858.cd013133.
42. H. I. Bulut et al., “A Comprehensive Review of Management Strategies for Bicuspid Aortic Valve (BAV): exploring epidemiology, aetiology, aortopathy, and interventions in light of recent guidelines,” Journal of Cardiovascular Development and Disease, vol. 10, no. 9, p. 398, Sep. 2023, doi: 10.3390/jcdd10090398.
43. S. Sakellaropoulos, M. Mohammed, S. Svab, D. Lekaditi, P. Sakellaropoulos, and A. Mitsis, “Causes, Diagnosis, risk Stratification and Treatment of Bicuspid Aortic valve Disease: An Updated review,” Cardiology Research, vol. 11, no. 4, pp. 205–212, Jan. 2020, doi: 10.14740/cr1061.
44. T. Niaz, S. M. Fernandes, S. P. Sanders, H. Michelena, and D. J. Hagler, “Clinical history and management of bicuspid aortic valve in children and adolescents,” Progress in Cardiovascular Diseases, vol. 63, no. 4, pp. 425–433, Jun. 2020, doi: 10.1016/j.pcad.2020.05.012.
45. R. D. Vanderlaan and D. J. Barron, “Optimal surgical management of tetralogy of Fallot,” CJC Pediatric and Congenital Heart Disease, vol. 2, no. 6, pp. 352–360, Sep. 2023, doi: 10.1016/j.cjcpc.2023.09.003.
46. H. Guné, J. Sjögren, M. Carlsson, R. Gustafsson, P. Sjöberg, and S. Nozohoor, “Right ventricular remodeling after conduit replacement in patients with corrected tetralogy of Fallot - evaluation by cardiac magnetic resonance,” Journal of Cardiothoracic Surgery, vol. 14, no. 1, Apr. 2019, doi: 10.1186/s13019-019-0899-6.
47. F. Windhausen et al., “Per-operative stent placement in the right pulmonary artery; a hybrid technique for the management of pulmonary artery branch stenosis at the time of pulmonary valve replacement in adult Fallot patients,” Netherlands Heart Journal, vol. 19, no. 10, pp. 432–435, Sep. 2011, doi: 10.1007/s12471-011-0195-0.
48. C. S. Broberg et al., “Long-Term outcomes after atrial switch operation for transposition of the great arteries,” Journal of the American College of Cardiology, vol. 80, no. 10, pp. 951–963, Aug. 2022, doi: 10.1016/j.jacc.2022.06.020.
49. H. Chubb, M. O’Neill, and E. Rosenthal, “Pacing and defibrillators in complex congenital heart disease,” Arrhythmia & Electrophysiology Review, vol. 5, no. 1, p. 57, Jan. 2016, doi: 10.15420/aer.2016.2.3.
50. R. R. Davies and C. Pizarro, “Decision‑Making for Surgery in the Management of Patients with Univentricular Heart,” Frontiers in Pediatrics, vol. 3, art. 61, Jul. 27, 2015, doi: 10.3389/fped.2015.00061
51. S. Gupta et al., “Congenital rubella: a salient cause of congenital heart defects in infants,” Journal of Tropical Pediatrics, vol. 67, no. 2, Apr. 2021, doi: 10.1093/tropej/fmab044.
52. D. J. S. Van Der Linde, C. M. H. De Groot, J. H. M. Mulder, M. J. M. Van Gelder, M. A. Zwinderman, L. J. P. Van Dijk, et al., “2020 ESC Guidelines for the management of adult congenital heart disease,” European Heart Journal, vol. 41, no. 10, pp. 1128–1201, Mar. 2020, doi: 10.1093/eurheartj/ehaa844.
53. M. Ladouceur, E. Valdeolmillos, C. Karsenty, S. Hascoet, P. Moceri, and L. L. Gloan, “Cardiac drugs in ACHD Cardiovascular Medicine,” Journal of Cardiovascular Development and Disease, vol. 10, no. 5, p. 190, Apr. 2023, doi: 10.3390/jcdd10050190.
54. J. A. Moore et al., "Hope is No Plan: Uncovering Actively Missing Transition-Aged Youth with Congenital Heart Disease," Pediatric Cardiology, vol. 43, no. 5, pp. 1046–1053, 2022, doi: 10.1007/s00246-022-02823-1.
55. P. Moons et al., "Discontinuity of Cardiac Follow-Up in Young People with Congenital Heart Disease Transitioning to Adulthood: A Systematic Review and Meta-Analysis," Journal of the American Heart Association, vol. 10, no. 6, e019552, 2021, doi: 10.1161/JAHA.120.019552.
56. M. S. Kollengode, C. J. Daniels, and A. N. Zaidi, "Loss of follow-up in transition to adult CHD: a single-centre experience," Cardiology in the Young, vol. 28, no. 8, pp. 1001–1008, 2018, doi: 10.1017/S1047951118000690.
57. P. P. Bassareo, M. Chessa, G. Di Salvo, K. P. Walsh, and C. J. McMahon, "Strategies to Aid Successful Transition of Adolescents with Congenital Heart Disease: A Systematic Review," Children, vol. 10, no. 3, p. 423, 2023, doi: 10.3390/children10030423.
58. S. S. Gaydos, S. M. Chowdhury, R. N. Judd, and K. E. McHugh, "A transition clinic intervention to improve follow-up rates in adolescents and young adults with congenital heart disease," Cardiology in the Young, vol. 30, no. 5, pp. 633–640, 2020, doi: 10.1017/S1047951120000682.
59. A. M. Strijbosch et al., "Transition from paediatric to adult care of adolescent patients with congenital heart disease: a pathway to optimal care," Netherlands Heart Journal, vol. 24, no. 11, pp. 682–690, 2016, doi: 10.1007/s12471-016-0900-0.
60. J. Gerardin et al., "Lost in the system? Transfer to adult congenital heart disease care—Challenges and solutions," congenital heart disease, vol. 14, no. 4, pp. 541–548, 2019, doi: 10.1111/chd.12780.
61. K. Uzark et al., "Transition Readiness in Teens and Young Adults with Congenital Heart Disease: Can We Make a Difference?" The Journal of Pediatrics, vol. 221, pp. 201–206.e1, 2020, doi: 10.1016/j.jpeds.2020.02.040.
62. M. Chessa et al., "Three-dimensional printing, holograms, computational modelling, and artificial intelligence for adult congenital heart disease care: An exciting future," European Heart Journal, vol. 43, no. 28, pp. 2672–2684, 2022. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/35608227/
63. S. Tarui, S. Sano, and H. Oh, "Stem cell therapies in patients with single ventricle physiology," Methodist DeBakey Cardiovascular Journal, vol. 10, no. 2, pp. 77–81, 2014, doi: 10.14797/mdcj-10-2-77.
64. U. Choubey et al., "Regenerating the ailing heart: Stem cell therapies for hypoplastic left heart syndrome," Annals of Pediatric Cardiology, vol. 17, no. 2, pp. 124–131, 2024, doi: 10.4103/apc. apc2424.
65. H. H.-P. Liu and D. Cortez, "Retrievable dual-chamber leadless pacemaker implant (Aveir DR) in an adult patient with congenital heart disease," Indian Pacing and Electrophysiology Journal, vol. 24, no. 6, pp. 347–350, 2024, doi: 10.1016/j.ipej.2024.09.001.